BIONDVAX PHARMACEUTICALS LTD's ticker is and the CUSIP is 09073Q204. A total of 13 filers reported holding BIONDVAX PHARMACEUTICALS LTD in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 190,927 | $269,207 | 0.22% |
| NewSquare Capital LLC | 2 | $3 | 0.00% |
| UBS Group AG | 306 | $431 | 0.00% |
| RHUMBLINE ADVISERS | 3,499 | $4,759 | 0.00% |
| CREDIT AGRICOLE S A | 424 | $598 | 0.00% |
| WELLS FARGO & COMPANY/MN | 20 | $28 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 11,578 | $15,746 | 0.00% |
| MORGAN STANLEY | 2,182 | $3,077 | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 10,921 | $14,853 | 0.00% |